KEMSA tender GF ATM HIV GC7/OIT04/2026-2027: supply of medicines for opportunistic infections (OIs)

What is being bought

Kenya Medical Supplies Authority (KEMSA) is tendering for the supply of medicines for opportunistic infections (OIs), under the Global Fund-funded reference GF ATM HIV GC7/OIT04/2026-2027. The tender has 2 lots (items) and deliveries are to KEMSA Warehouse in Nairobi, Kenya. Quantities are in the Schedule of Requirements, which was not reviewed.

Key facts

Closing

Thu 29 Oct 2026, 10:00 am
Tender closing and submission deadline: 29 October 2026 at 10:00 a.m. local time (portal shows 2026-10-29 10:00:00). No addenda reviewed. D2 p.31

Bid / tender security

Original bid security of USD 6,000.00 or KES 774,000.00 or equivalent in freely convertible currency, valid 240 days from date of tender opening. Electronic tender securities acceptable, authenticated via QR scanner. D2 p.39

Tender fee

Not stated in the documents we reviewed Not stated D2

Site visit

Not stated in the documents we reviewed Not stated D2

Pre-bid meeting

Not stated in the documents we reviewed Not stated D2

Reserved for

Not reserved. International competitive tender; open to all interested tenderers. D2 p.22

Contract value

Not stated in the documents we reviewed Not stated D2

Tender opening

Tender opening at KEMSA Tender Opening/Conference Hall, National Supply Chain Centre, Embakasi Off Airport North Road, Nairobi, same date and time as closing. D2 p.31

Tender validity

Tender validity period is 210 days. D2 p.30

Who can apply

• A tenderer may be a private firm, a state-owned enterprise, or a joint venture (JV) of such entities; the maximum number of JV members is 3. D2 p.30

Application checklist

Tick items off as you prepare. Your ticks stay on this device only.

Required from every bidder

• Copy of Certificate of Incorporation/Registration. D2 p.39
• Copy of valid and current Tax Compliance Certificate (for local bidders). D2 p.39
• Tender form on letterhead showing the tenderer's complete name and business address, duly completed and signed, with power of attorney where applicable. D2 p.39
• Tenderer's Eligibility Confidential Business Questionnaire, completed and signed. D2 p.39
• Certificate of Independent Tender Determination, completed and signed. D2 p.39
• Self-declarations, completed and signed: not debarred from PPADA 2015 procurement; will not engage in corrupt or fraudulent practice; declaration and commitment to the code of ethics. D2 p.39
• Current and valid Good Manufacturing Practice (GMP) certificate issued by an independent regulatory authority. D2 p.38
• For products registered within the year, Product Registration certificate from the Pharmacy and Poisons Board of Kenya; for products registered in prior years, a valid Product Retention Certificate with QR codes. D2 p.38
• Current and valid Manufacturing License. D2 p.40
• Tender documents must be paginated in continuous ascending order from the first page to the last (1, 2, 3... n). D2 p.39

Required only in some situations

• Manufacturer's Authorization on the manufacturer's letterhead, addressed to KEMSA, tender and item specific, signed by an authorized signatory (for bidders who are not manufacturers). D2 p.38
• Current and valid wholesale dealers licence with QR codes from the Pharmacy and Poisons Board of Kenya (applicable to local bidders). D2 p.40
• Current and valid Superintendent Pharmacist practising licence with QR codes from the Pharmacy and Poisons Board of Kenya (applicable to local bidders). D2 p.40

Experience, licences and financial capacity

Technical

• Products must be prequalified by the WHO Prequalification Programme and/or authorized by a Stringent Regulatory Authority (SRA) per the Global Fund Quality Assurance Policy. D2 p.30
• A sample for product evaluation must be submitted under separate cover at or before the tender closing date and time, clearly labelled with tenderer's name, tender reference and product identification, and must represent exactly the product to be supplied. Inconsistent samples lead to rejection of that item's offer. A certificate of analysis from the manufacturer's lab for the same batch is required on award. D2 p.30
• For each health product, documentary evidence that it is manufactured to the latest monographs and meets standards of the International, British, United States or European Pharmacopoeia, or manufacturer's specifications. D2 p.30
• Goods must be registered with the Pharmacy and Poisons Board in Kenya. D2 p.30
• Product evaluation of samples is Yes/No on physical properties, packaging and labelling against the tender specifications. D2 p.39

Financial

• Post-qualification (if applicable): evidence of maximum 3 supply contracts for health products within past 3 years equal to the contract sum, one at least 60% of the tender sum; average annual turnover over last 3 years equivalent to the tender sum with certified financial statements; annual production capacity statement at least three times contract quantities. D2 p.39

How and where to submit

• Hard copy submission only; electronic submission not permitted. Original tender plus 1 copy, addressed to the Chief Executive Officer, KEMSA, National Supply Chain Centre, Embakasi Off Airport North Road, P.O. Box 47715-00100, Nairobi. D2 p.31
• Number of copies: the original plus 1 copy. D2 p.31
• Authorisation to sign: a written Power of Attorney. D2 p.31

Lots and categories

• Lot 2 lots: The tender comprises 2 lots (contracts). Tenderers are evaluated per lot and the lowest evaluated tenderer is identified for each lot. D2 p.30

What the addenda changed

• No addenda reviewed. Not stated P

Not covered in the documents we reviewed

• Schedule of Requirements (Section V) with item list, quantities and delivery dates
• Tender-specific Form of Tender price schedule and total tender sum
• Full Section IX Special Conditions of Contract and payment terms
• Any addenda or clarifications issued after the tender document
• Confirmation of Pharmacy and Poisons Board registration requirements details and forms beyond those reviewed
• Details of performance security and contract signing requirements
• Remaining pages of Section III, Section IV forms and Section VIII General Conditions

Terms explained

Tender security

A guarantee or security deposit submitted with the bid to show the bidder is serious; here USD 6,000 or KES 774,000.

TDS

Tender Data Sheet: the tender-specific section giving particular values that override the general instructions.

AGPO

Affirmative action groups (youth, women, persons with disability) that may get reserved tenders; not applicable here.

Responsive

A tender that meets all mandatory requirements and is not rejected at preliminary examination.

JV

Joint venture: several firms bidding together as one tender.

WHO Prequalification / SRA

WHO Prequalification Programme or Stringent Regulatory Authority approval of a medicine's quality.

DAP

Delivered at place: seller delivers goods to named destination, here the KEMSA warehouse in Nairobi, risk passing on arrival.

Power of Attorney

Written authority allowing a person to sign the tender on the company's behalf.